Solicitation from the Department of Justice, Drug Enforcement Administration (DEA), is seeking a contractor to evaluate the abuse potential of synthetic opioids and other depressants through in vivo pharmacological studies. The DEA Diversion Control Division requires the contractor to provide investigational study results and a description of the methodology used to conduct the investigation. This evaluation is crucial in determining the abuse potential of these substances.